| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 86 | 340 | 1,010 | $100 | $511K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 110 | 260 | 860 | $80 | $222.6K |
| 0241U | N/A | 32 | 40 | 150 | $120 | $65.1K |
| 90471 | In this procedure, the provider administers a live attenuated vaccine using a percutaneous, intradermal, subcutaneous, or intramuscular route. | 64 | 160 | 180 | $40 | $59.6K |
| W0037 | N/A | 84 | 160 | 690 | $20 | $50.1K |
| 90472 | This code represents each injection of a vaccine after the first; list this code in addition to the code for the first injection. | 62 | 70 | 450 | $20 | $29.2K |
| 87880 | The analyst performs an immunoassay with direct optical, meaning visual, observation to detect Streptococcus, group A, in a patient sample, typically a throat swab. | 57 | 80 | 210 | $30 | $18K |
| 87804 | The analyst performs an immunoassay with direct optical, meaning visual, observation to detect influenza, also called flu, in a patient sample, typically a throat or nasal swab or nasal washings. | 52 | 70 | 210 | $20 | $14.7K |
| 90686 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL… | 91 | 130 | 110 | $10 | $6.9K |
| 87811 | The lab analyst performs the technical lab test to analyze for the presence of severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) (Coronavirus disease [COVID–19]) in a specimen by… | 10 | 10 | 50 | $20 | $970 |